Sector consensus Genmab A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 02:43:02 08/05/2026 pm IST			5-day change	1st Jan Change
1,566.50 ^DKK	-10.92%		-7.70%	-22.87%

10:43am	Goldman Sachs raises Genmab price target to DKK 2,300 (2,200), reiterates Buy - BN	FW
08/05	Genmab A/S Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
GENMAB A/S			2,350.09	+33.64%	14
ARGENX SE			844.81	+25.87%	15
WUXI APPTEC CO., LTD.			145.41	+30.67%	17
INSMED INCORPORATED			211.65	+101.57%	20
BIONTECH SE			110.28	+39.33%	18
WUXI BIOLOGICS (CAYMAN) INC.			40.13	+38.24%	21
AKESO, INC.			150.59	+25.22%	21
SUMMIT THERAPEUTICS INC.			22.32	+76.19%	14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			533.85	+17.33%	17
MADRIGAL PHARMACEUTICALS, INC.			669.18	+25.11%	11
EXELIXIS, INC.			49.06	+6.16%	17
ARROWHEAD PHARMACEUTICALS, INC.			84.5	+8.4%	12
CYTOKINETICS, INCORPORATED			102.95	+38.58%	19
REMEGEN CO., LTD.			96.82	+9.37%	15
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	7,70,000	+46.39%	1
IMMUNITYBIO, INC.			15.75	+102.96%	4
VAXCYTE, INC.			109	+111.73%	9
NUVALENT, INC.			142.54	+39.2%	18
PHARMAESSENTIA CORPORATION			766.5	+16.31%	6
Average			40,865.55	+41.70%	14
Weighted average by Cap.			22,305.63	+39.04%	15